Cabaletta Bio, Inc.
CABA
$1.21
$0.054.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -56.02% | -86.22% | -90.53% | -57.99% | -33.10% |
| Total Depreciation and Amortization | 39.29% | 19.44% | 15.14% | 7.67% | -6.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 77.55% | 137.47% | 101.38% | 58.65% | -24.62% |
| Change in Net Operating Assets | 339.45% | 428.83% | 96.77% | -2,808.45% | 147.70% |
| Cash from Operations | -40.58% | -61.24% | -74.86% | -90.26% | -35.59% |
| Capital Expenditure | -103.24% | -289.23% | -1,250.88% | -113.68% | 41.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 846.25% | -- | 150.95% | -- | -- |
| Cash from Investing | 967.25% | 18,941.54% | 149.29% | -103.30% | 459.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.34% | -27.55% | -99.60% | 1,396.72% | 182.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.30% | -27.55% | -99.60% | 2,933.19% | 182.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.55% | 36.32% | -90.30% | -246.63% | 280.24% |